0000899243-21-001359.txt : 20210111
0000899243-21-001359.hdr.sgml : 20210111
20210111173152
ACCESSION NUMBER: 0000899243-21-001359
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210107
FILED AS OF DATE: 20210111
DATE AS OF CHANGE: 20210111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Keane Raymond T
CENTRAL INDEX KEY: 0001448434
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39856
FILM NUMBER: 21521777
MAIL ADDRESS:
STREET 1: C/O ARIAD PHARMACEUTICALS, INC.
STREET 2: 26 LANDSDOWNE STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Cullinan Management, Inc.
CENTRAL INDEX KEY: 0001789972
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 813867811
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 520
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-410-4650
MAIL ADDRESS:
STREET 1: ONE MAIN STREET
STREET 2: SUITE 520
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Cullinan Oncology, LLC
DATE OF NAME CHANGE: 20191001
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-01-07
0
0001789972
Cullinan Management, Inc.
CGEM
0001448434
Keane Raymond T
C/O CULLINAN MANAGEMENT, INC.
ONE MAIN STREET, SUITE 520
CAMBRIDGE
MA
02142
0
1
0
0
Chief Legal Officer
Stock Option (Right to Buy)
21.00
2021-01-07
4
A
0
249998
0.00
A
2031-01-06
Common Stock
249998
249998
D
The option represents a right to purchase a total of 249,998 shares of the Issuer's Common Stock, 25% of which will become fully vested and exercisable on January 7, 2022, with the remaining shares vesting in equal monthly installments over the following three years (36 months), subject to the reporting person's continued employment with the Issuer.
/s/ Jeffrey Trigilio, Attorney-in-Fact
2021-01-07